Knowledge about cervical cancer, Pap test, and barriers to women’s participation in screening in Belgrade, Serbia

Introduction: Cervical cancer (CC) is a serious public health concern in Serbia, due to opportunistic screening still being in force, which led to twice higher than the average incidence rate of cervical cancer in Europe. Despite the fact that early detection and treatment services of CC are available at no additional cost, majority of women use inadequate screening services in Serbia. Objective: This study aimed to examine the link between the knowledge about CC and Papanicolaou (Pap) test and perception of barriers to women’s participation in CC screening. Materials and Methods: The study included 300 women aged 21 to 69, with a place of residence in the city of Belgrade (Serbia), who were attending for their medical examination to the University Clinic of Gynecology and Obstetrics - "Narodni front", from June through December 2014. A survey instrument to collect data was an adapted questionnaire for the assessment of knowledge about and barriers to CC and Pap test. Patients were divided into three groups: a study group consisted of women attending irregularly (over three years), women who never participated in screening, and a control group that included women regularly participating in screening. Results: Women regularly participating in screening (52.7%) had adequate knowledge about CC and Pap test, while women who irregularly (79.4%) or never participated (71.9%) did not have any adequate knowledge. There was a significant statistical difference between the CC and Pap test awareness in a group of respondents who regularly participated in comparison to respondents who irregularly or never participated in screening (χ² = 27.772, p = 0.000). Regarding knowledge about human papillomavirus (HPV), 80% of women did not know that Pap test cannot be used for detection of HPV, as well as that abnormal Pap test result may be due to HPV (61.7%). Majority of women (93.7%) had poor knowledge about Pap test role in CC early detection and considered Pap test to be used to diagnose CC. The authors found a significant statistical correlation between participation of women in screening and barriers. Women who were irregular or never participated, had barriers such as: lack of time (F = 9.51; p = 0,000), difficult access to Healthcare facilities (F = 11.29; p = 0.000), lack of knowledge about the Pap test procedure (F = 21.27, p = 0.000), discomfort (F = 9.36; p = 0.000), and anxiety of Pap test results (F = 3.35; p = 0.036). Women who regularly participated did not have prejudice when choosing a gynecologist, unlike the other two groups that preferred a female gynecologist (F = 3.61; p = 0.028). Conclusion: This study showed that the level of knowledge about CC and Pap test in women is an important factor associated with regular participation in screening. It is necessary to take educational measures in order to raise awareness of women regarding risk factors, as well as to overcome fear and shame, with the ultimate aim to reduce frequency and mortality rate caused by CC in Serbia.

Cervical cancer; Knowledge; Barriers; Papanicolaou smear screening.

[1] Ferlay J., Shin HR., Bray F., et al.:“GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide“. IARC Cancer Base No.10. Lyon, France: International Agency for Research on Cancer, 2010. Available at: http://globocan.iarc.fr

[2] Republic of Serbia Ministry of Health: “Technical Assistance for the implementation of the National screening programme for colorectal, cervical and breast cancer in Serbia”. April 2013. Available at: http://arhivaprojekta.skriningsrbija.rs/sites/default/files/Nacionalni% 20program%20organizovanog%20skrininga%20raka%20 grlica%20%20materice.pdf

[3] Jovanović A.M., Dikic S.D., Jovanovic V., Zamurovic M., Nikolic B., Krsic V., et al.: “Corelation of human papillomavirus infection with cytology,colposcopy and histopathological examination of the bioptic tissue in low and high grade intraepithelial lesions“. Eur. J. Gynaecol. Oncol., 2012, 5, 512.

[4] Oranratanaphan S., Amatyakul P., Iramaneerat K., Suchila S.: “Knowledge, attitudes and practices about the Pap smear among medical workers in Naresuan University Hospital, Thailand“. Asian Pac. J. Cancer Prev., 2010, 11, 1727.

[5] Läärä E., Day N.E., Hakama N.: “ Trends in mortality from cervical cancer in the Nordic countries“.Lancet., 1987,1, 1247.

[6] Bastos J., Peleteiro B., Gouveia J., Coleman MP., Lunet N.: “The state of theart of cancer control in 30 European countries in 2008“. Int. J. Cancer, 2010, 126, 2700.

[7] Levi F., Lucchini F., Negri E., Franceschi S., la Vecchia C.: “Cervical cancer mortality in young women in Europe: patterns and trends“. Eur. J. Cancer, 2000, 36, 2266.

[8] Kumar V., Abbas A.K., Fausto N., Mitchell R.N.: “Robbins Basic Pathology. 8thed. Philadelphia: Saunders Elsevier, 2007, 718.

[9] World Health Organization (WHO): Global burden of disease report: Causes of death in 2004. Global Burden of Disease Report”. Geneva: WHO, 2004. Available at: http://www.who.int/healthinfo/global_burden_ disease/GBD_report_2004update_full.pdf

[10] Fiebig D., Haas M., Hossain I., Street D., Viney R.: “Decisions about Pap tests: What influences women and providers?” Soc. Sci. Med., 2009, 68, 1766.

[11] Matejić B., Vuković D., Pekmezović T., Kesić V., Marković M.: “Determinants of preventive health behavior in relation to cervical cancer screening among the female population of Belgrade”. Health Educ. Res., 2011, 26, 201.

[12] N Ebu., S. Cmupepi., M. Siakwa., C. Sampselle.: “Knowledge, practice, and barriers toward cervical cancer screening in Elmina, Southern Ghana“. Int. J. Womens Health, 2014, 7, 31.

[13] Thippeveeranna C., Mohan S.S., Singh L.R., Singh N.N.: “Knowledge, Attitude and Practice of the Pap Smear as a Screening Procedure Among Nurses in a Tertiary Hospital in North Eastern India”. Asian Pac. J. Cancer Prev., 2013, 14, 849.

[14] Zahedi L., Sizemore E., Malcolm S., Grossniklaus E., Nwosu O.: “Knowledge, Attitudes and Practices Regarding Cervical Cancer and Screening among Haitian Health Care Workers”. Int. J. Environ. Res. Public Health, 2014, 11, 11541.

[15] Moreira E.D Jr., Oliveira B.G., Ferraz F.M., Costa S., Costa Filho J.O., Karic G.: “Knowledge and attitudes about human papillomavirus, Pap smears, and cervical cancer among young women in Brazil: Implications for health education and prevention“. Int. J. Gynecol. Cancer, 2006, 16, 599.

[16] Tiro JA, Meissner HI, Kobrin S, Chollette V.: ”What do women in the U.S. know about human papillomavirus and cervical cancer?” Cancer Epidemiol. Biomarkers Prev., 2007, 16, 288.

[17] Urrutia M.T., Hall R.: “Beliefs about cervical cancer and Pap test: a new Chilean questionnaire”. J. Nurs. Scholarsh., 2013, 45, 126.

[18] Ibekwe C.M., Hoque M.E., Ntuli-Ngcobo B.: “Perceived benefits of cervical cancer screening among women attending Mahalapye District Hospital, Botswana“. Asian Pac. J. Cancer Prev., 2010, 11, 1021.

[19] Ncube B., Bey A., Knight J., Bessler P., Jolly P.E.: “Factors Associated with the Uptake of Cervical Cancer Screening Among Women in Portland, Jamaica”. N. Am. J. Med. Sci., 2015, 7, 104.

[20] Gichangi P., Estambale B., Bwayo J., Rogo K., Ojwang S., Opiyo A., Temmerman M.: “Knowledge and practice about cervical cancer and Pap smear testing among patients at Kenyatta National Hospital, Nairobi, Kenya”. Int. J. Gynecol Cancer, 2003, 13, 827.

[21] Lamadrid A. S.: “Knowledge and fears among Chilean women with regard to the Papanicolaou test”. Bull. Pan. Am. Health Organ, 1996, 30, 354.

[22] Waller J., McCaffery K., Forrest S., Szarewski A., Cadman L., Wardle J.: “Awareness of human papilloma virusamong women attending a well woman clinic”. Sex. Trans. Infect., 2003, 79, 320.

[23] Tacken M.A., Braspenning J.C., Hermens R.P., Spreeuwenberg P.M., van den Hoogen H.J., de Bakker D.H., et al.: “Uptake of cervical cancer screening in the Netherlands is mainly influenced by women's beliefs about the screening and by the inviting organization“. Eur. J. Pub. Health, 2007, 17, 178.

[24] Kabir M., Iliyasu Z., Abubakar I.S., Mahboob S.: “Awareness and Practice of Cervical Cancer Screening among female professional health workers in Murtala Mohammed Specialist Hospital Kano”. Nig. Postgrad. Med. J., 2005, 12, 179.

[25] Were E., Nyaberi Z., Buziba N.:“Perceptions of risk and barriers to cervical cancer screening at Moi Teaching and Referral Hospital (MTRH), Eldoret, Kenya”. Afr. Health Sci., 2011, 11, 58.

[26] Fort V.K., Makin M.S., Siegler A.J., Ault K., Rochat R.: “Barriers to cervical cancer screening in Mulanje, Malawi: a qualitative study”. Patient Prefer. Adherence, 2011, 5, 125.

[27] Steven D., Fitch M., Dhaliwal H., Kirk-Gardner R., Sevean P., Jamieson J.: “Knowledge, attitudes, beliefs, and practices regarding breast and cervical cancer screening in selected ethnocultural groups in Northwestern Ontario”. Oncol. Nurs. Forum, 2004, 31, 305.

[28] Kitchener H.C., Castle P.E., Cox J.T.:“Chapter 7: achievements and limitations of cervical cytology screening“. Vaccine., 2006, 24, 63.

[29] Cann, J.: “Cervical Screening. Study on the prevalence of risk factors for developing cervical cancer among young women”. Dublin Institute of Technology, 2008, Available at: http://arrow.dit.ie/aaschssldis/19

[30] Arulogun O.S., Maxwell O.O.:“Perception and utilization of cervical cancer screening services among female nurses in University College Hospital, Ibadan, Nigeria“. Pan Afr. Med. J., 2012, 11, 69.

[31] Factors affecting health seeking behaviour among Kelantanese women on Pap smear screening”. International Conference on Humanities, Society and Culture IPEDR, Vol. 20, Singapore, IAC-SIT Press, 2011.

[32] Gatune J.W., Nyamongo I.K.:“An ethnographic study of cervical cancer among women in rRural Kenya: is there a folk causal model?” Int. J. Gynecol. Cancer, 2005, 15, 1049.

[33] Wall K.M., Rocha G.M., Salinas-Martínez A.M., Baraniuk S., Day R.S.: “Modifiable Barriers to Cervical Cancer Screening Adherence among Working Women in Mexico”. J. Womens Health (Larchmt.), 2009, 19, 1263.

[34] Drolet M., Brisson M., Maunsell E., Franco E.L., Coutlée F., Ferenczy A., et al.: “The Psychosocial Impact of an Abnormal Cervical Smear Result”. Psychooncology, 2012, 10, 1071.